Minghui has reported positive topline outcomes from the Phase III trial of MH004 for treating mild to moderate atopic ...

Tryptamine Therapeutics (Tryp) has announced the completion of subject dosing in a Phase Ib clinical trial of TRP-8803, for ...

Aulos Bioscience has announced the first patients have been dosed as part of a trial investigating avelumab, marketed as ...

The Phase I trial of the combination therapy saw a an approximate 66% rate of near-complete remission in its cohort of breast ...

The Phase III trial of AXS-12 showed results over placebo as the company looks towards a new drug application for its ...

MSD has reported that the Phase III ZENITH trial of WINREVAIR for pulmonary arterial hypertension met its primary endpoint.

AstraZeneca has reported positive results from a Phase III trial that evaluated Truqap combined with abiraterone and ADT for ...

The announcement means the company will be pulling the plug on the CardinALS trial after its ALS drug failed to halt disease ...

As the first cohort of patients are dosed in the Phase II trial, multiple new trial sites are added for the glioblastoma ...

The results demonstrate the safety and efficacy of Fasenra in the treatment of acute eosinophilic exacerbations in asthma and ...

The Global Coalition for Adaptive Research (GCAR) has executed an agreement to evaluate AstraZeneca's AZD1390 in the GBM ...

Following the ReThink study failure, Cassava Sciences is discontinuing the Phase III ReFocus trial and open-label study.